{"id":47453,"date":"2022-08-18T18:02:07","date_gmt":"2022-08-18T16:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/"},"modified":"2022-08-18T18:02:07","modified_gmt":"2022-08-18T16:02:07","slug":"global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/","title":{"rendered":"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2229064\/global_metabolic_partnering_20152020_deal?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=kfxpml&amp;utm_campaign=1739906+-+Global+Metabolic+Partnering+Report+2022%3A+Deal+Trends%2C+Players+and+Financials+Analysis+of+1100%2B+Deals+Signed+Since+2015&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Metabolic Partnering 2015-2022: Deal trends, players and financials&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220818005603\/en\/1548164\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220818005603\/en\/1548164\/21\/logo.jpg\"><\/a><\/p>\n<p>\nGlobal Metabolic Partnering 2015 to 2022 provides the full collection of 1100+ Metabolic disease deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2015.\n<\/p>\n<p>\nMost of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor&#8217;s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&amp;D and a commercialization of outcomes element.\n<\/p>\n<p>\nThe report takes readers through the comprehensive Metabolic disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Metabolic deals.\n<\/p>\n<p>\nThe report presents financial deal terms values for Metabolic deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.\n<\/p>\n<p>\n<strong>The initial chapters of this report provide an orientation of Metabolic dealmaking trends.<\/strong>\n<\/p>\n<p>\nChapter 1 provides an introduction to the report.\n<\/p>\n<p>\nChapter 2 provides an overview of the trends in Metabolic dealmaking since 2015 covering trends by year, deal type, stage of development, technology type and therapeutic indication.\n<\/p>\n<p>\nChapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.\n<\/p>\n<p>\nChapter 4 provides a review of the leading Metabolic deals since 2015. Deals are listed by headline value. The chapter includes the top 25 most active Metabolic dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.\n<\/p>\n<p>\nChapter 5 provides comprehensive access to Metabolic deals since 2015 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.\n<\/p>\n<p>\nChapter 6 provides a comprehensive directory of all Metabolic partnering deals by specific Metabolic target announced since 2015. The chapter is organized by specific Metabolic therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.\n<\/p>\n<p>\nIn addition, a comprehensive appendix is provided with each report of all Metabolic partnering deals signed and announced since 2015. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&amp;D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.\n<\/p>\n<p>\nThe report includes deals for the following indications: Acromegaly, Addison&#8217;s disease, Cirrhosis, Cushing&#8217;s syndrome, Diabetes, Type 1, Type 2, Insipidus, Fatty liver, Gallstones, Goitre, Growth hormone disorders, Gynaecomastia, Inborn errors of metabolism, Phenylketonuria, Hyperaldosteronism, Hypercalcaemia, Hyperthyroidism, Hypocalcaemia, Hypogonadism, Hypopituitarism, Hypothyroidism, Liver disease, Nonalcoholic steatohepatitis (NASH), Lysosomal storage disorders, Nutrition and vitamins, Rickets, Pheochromocytoma, Primary bilary cirrhosis, Prolactinemia, Short stature, Syndrome of Inappropriate Antidiuretic Hormone (SIADH), Thyroid disease, plus other metabolic indications.\n<\/p>\n<p>\n<strong>Report scope<\/strong>\n<\/p>\n<p>\n<strong>Global Metabolic Partnering 2015 to 2022 includes:<\/strong>\n<\/p>\n<ul>\n<li>\nTrends in Metabolic dealmaking in the biopharma industry since 2015\n<\/li>\n<li>\nAccess to headline, upfront, milestone and royalty data\n<\/li>\n<li>\nAccess to hundreds of Metabolic deal contract documents\n<\/li>\n<li>\nComprehensive access to over 1100 Metabolic deal records\n<\/li>\n<li>\nThe leading Metabolic deals by value since 2015\n<\/li>\n<li>\nMost active Metabolic dealmakers since 2015\n<\/li>\n<\/ul>\n<p>\n<strong>In Global Metabolic Partnering 2015 to 2022, available deals and contracts are listed by:<\/strong>\n<\/p>\n<ul>\n<li>\nHeadline value\n<\/li>\n<li>\nUpfront payment value\n<\/li>\n<li>\nRoyalty rate value\n<\/li>\n<li>\nStage of development at signing\n<\/li>\n<li>\nDeal component type\n<\/li>\n<li>\nTechnology type\n<\/li>\n<li>\nSpecific therapy indication\n<\/li>\n<\/ul>\n<p>\n<strong>Analyzing actual contract agreements allows assessment of the following:<\/strong>\n<\/p>\n<ul>\n<li>\nWhat are the precise rights granted or optioned?\n<\/li>\n<li>\nWhat is actually granted by the agreement to the partner company?\n<\/li>\n<li>\nWhat exclusivity is granted?\n<\/li>\n<li>\nWhat is the payment structure for the deal?\n<\/li>\n<li>\nHow are the sales and payments audited?\n<\/li>\n<li>\nWhat is the deal term?\n<\/li>\n<li>\nHow are the key terms of the agreement defined?\n<\/li>\n<li>\nHow are IPRs handled and owned?\n<\/li>\n<li>\nWho is responsible for commercialization?\n<\/li>\n<li>\nWho is responsible for development, supply, and manufacture?\n<\/li>\n<li>\nHow is confidentiality and publication managed?\n<\/li>\n<li>\nHow are disputes to be resolved?\n<\/li>\n<li>\nUnder what conditions can the deal be terminated?\n<\/li>\n<li>\nWhat happens when there is a change of ownership?\n<\/li>\n<li>\nWhat sublicensing and subcontracting provisions have been agreed?\n<\/li>\n<li>\nWhich boilerplate clauses does the company insist upon?\n<\/li>\n<li>\nWhich boilerplate clauses appear to differ from partner to partner or deal type to deal type?\n<\/li>\n<li>\nWhich jurisdiction does the company insist upon for agreement law?\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 &#8211; Introduction<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 &#8211; Trends in Metabolic dealmaking<\/strong>\n<\/p>\n<p>\n2.1. Introduction\n<\/p>\n<p>\n2.2. Metabolic partnering over the years\n<\/p>\n<p>\n2.3. Metabolic partnering by deal type\n<\/p>\n<p>\n2.4. Metabolic partnering by industry sector\n<\/p>\n<p>\n2.5. Metabolic partnering by stage of development\n<\/p>\n<p>\n2.6. Metabolic partnering by technology type\n<\/p>\n<p>\n2.7. Metabolic partnering by therapeutic indication\n<\/p>\n<p>\n<strong>Chapter 3 &#8211; Financial deal terms for Metabolic partnering<\/strong>\n<\/p>\n<p>\n3.1. Introduction\n<\/p>\n<p>\n3.2. Disclosed financials terms for Metabolic partnering\n<\/p>\n<p>\n3.3. Metabolic partnering headline values\n<\/p>\n<p>\n3.4. Metabolic deal upfront payments\n<\/p>\n<p>\n3.5. Metabolic deal milestone payments\n<\/p>\n<p>\n3.6. Metabolic royalty rates\n<\/p>\n<p>\n<strong>Chapter 4 &#8211; Leading Metabolic deals and dealmakers<\/strong>\n<\/p>\n<p>\n4.1. Introduction\n<\/p>\n<p>\n4.2. Most active in Metabolic partnering\n<\/p>\n<p>\n4.3. List of most active dealmakers in Metabolic\n<\/p>\n<p>\n4.4. Top Metabolic deals by value\n<\/p>\n<p>\n<strong>Chapter 5 &#8211; Metabolic contract document directory<\/strong>\n<\/p>\n<p>\n5.1. Introduction\n<\/p>\n<p>\n5.2. Metabolic partnering deals where contract document available\n<\/p>\n<p>\n<strong>Chapter 6 &#8211; Metabolic dealmaking by therapeutic target<\/strong>\n<\/p>\n<p>\n6.1. Introduction\n<\/p>\n<p>\n6.2. Deals by Metabolic therapeutic target\n<\/p>\n<p>\n<strong>Appendices<\/strong>\n<\/p>\n<p>\nAppendix 1 &#8211; Directory of Metabolic deals by company A-Z since 2015\n<\/p>\n<p>\nAppendix 2 &#8211; Directory of Metabolic deals by deal type since 2015\n<\/p>\n<p>\nAppendix 3 &#8211; Directory of Metabolic deals by stage of development since 2015\n<\/p>\n<p>\nAppendix 4 &#8211; Directory of Metabolic deals by technology type since 2015\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2229064\/global_metabolic_partnering_20152020_deal?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=kfxpml&amp;utm_campaign=1739906+-+Global+Metabolic+Partnering+Report+2022%3A+Deal+Trends%2C+Players+and+Financials+Analysis+of+1100%2B+Deals+Signed+Since+2015&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/7b8gbu<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;&#x6c;&#116;&#111;&#x3a;&#x70;&#114;&#101;&#x73;&#x73;&#64;&#114;&#x65;&#x73;&#101;&#97;&#x72;&#x63;&#104;&#97;&#x6e;&#x64;&#109;&#97;&#x72;&#x6b;&#101;&#116;&#x73;&#x2e;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">pr&#101;&#115;&#115;&#x40;&#x72;&#x65;&#x73;&#x65;ar&#99;&#104;&#97;&#x6e;&#x64;&#x6d;&#x61;&#x72;ke&#116;&#115;&#46;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Metabolic Partnering 2015-2022: Deal trends, players and financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Metabolic Partnering 2015 to 2022 provides the full collection of 1100+ Metabolic disease deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2015. Most of the deals included within the report occur when a licensee &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47453","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Metabolic Partnering 2015-2022: Deal trends, players and financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Metabolic Partnering 2015 to 2022 provides the full collection of 1100+ Metabolic disease deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2015. Most of the deals included within the report occur when a licensee ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-18T16:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220818005603\/en\/1548164\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-18T16:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/\"},\"wordCount\":1006,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005603\\\/en\\\/1548164\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/\",\"name\":\"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005603\\\/en\\\/1548164\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-18T16:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005603\\\/en\\\/1548164\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005603\\\/en\\\/1548164\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Metabolic Partnering 2015-2022: Deal trends, players and financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Metabolic Partnering 2015 to 2022 provides the full collection of 1100+ Metabolic disease deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2015. Most of the deals included within the report occur when a licensee ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-18T16:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220818005603\/en\/1548164\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 &#8211; ResearchAndMarkets.com","datePublished":"2022-08-18T16:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/"},"wordCount":1006,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220818005603\/en\/1548164\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/","name":"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220818005603\/en\/1548164\/21\/logo.jpg","datePublished":"2022-08-18T16:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220818005603\/en\/1548164\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220818005603\/en\/1548164\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-metabolic-partnering-report-2022-deal-trends-players-and-financials-analysis-of-1100-deals-signed-since-2015-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47453"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47453\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}